^
    CANCER:

    Maxillary Sinus Carcinoma

    No biomarker
    Maxillary Sinus Carcinoma
    VC
    Sensitive: A2 - Guideline
    No biomarker
    Maxillary Sinus Carcinoma
    EP
    Sensitive: A2 - Guideline
    No biomarker
    Maxillary Sinus Carcinoma
    CAV
    Sensitive: A2 - Guideline
    MSI-H/dMMR
    Maxillary Sinus Carcinoma
    pembrolizumab
    Sensitive: A2 - Guideline
    No biomarker
    Maxillary Sinus Carcinoma
    pembrolizumab + cetuximab
    Sensitive: A2 - Guideline
    No biomarker
    Maxillary Sinus Carcinoma
    pembrolizumab
    Sensitive: A2 - Guideline